{"response":{"docs":[{"system_create_dtsi":"2021-11-04T23:13:05Z","system_modified_dtsi":"2021-11-21T02:59:26Z","has_model_ssim":["PublishedWork"],"id":"000031935","accessControl_ssim":["dfb839f0-0b68-4748-b7f6-fc3da5bd4667"],"hasRelatedMediaFragment_ssim":["bg257k19n"],"hasRelatedImage_ssim":["bg257k19n"],"depositor_ssim":["batchuser@example.com"],"depositor_tesim":["batchuser@example.com"],"title_tesim":["Getting the right medicines? : putting public interests at the heart of health-related research."],"date_uploaded_dtsi":"2021-11-04T23:13:05Z","date_modified_dtsi":"2021-11-11T07:28:28Z","isPartOf_ssim":["admin_set/default"],"biblionumber_tesim":["31935"],"abstract_tesim":["Since its beginnings, the NHS has had a close relationship with the pharmaceutical industry. While not an official public-private partnership (PPP) there has been, in effect, an implicit PPP for pharmaceutical research and provision. This partnership has been an undoubted economic success. However, the interests of users of the health care system do not always coincide with what will be most profitable for the pharmaceutical industry. This publication argues that, because it is focussed on new medicinal drugs, the implicit PPP for pharmaceuticals neglects other research areas that may be beneficial for promoting people's health. It also omits key user groups and is therefore in danger of failing to meet the health needs of the very people it is supposed to be benefiting. It highlights where changes can be made to ensure there are sufficient incentives for research to tackle neglected areas that could be of value for improving health. It points the way forward towards a more transparent process with an emphasis on user involvement, and sets out the agenda on which future arrangements between the industry and the government should be negotiated."],"date_published_tesim":["2003"],"date_published_ssi":"2003","isbn_tesim":["1857174836"],"pagination_tesim":["54"],"place_of_publication_tesim":["London"],"rights_statement_tesim":["http://rightsstatements.org/vocab/InC/1.0/"],"license_tesim":["http://creativecommons.org/licenses/by-nc-nd/4.0/"],"creator_tesim":["Harrison, Anthony","The King's Fund"],"date_tesim":["2003"],"date_ssi":"2003","publisher_tesim":["King's Fund"],"resource_type_tesim":["Monograph"],"subject_tesim":["Pharmaceutical industry","Drugs","Health needs","Nhs","General public","Research"],"note_tesim":["Pagination: xi, 54p."],"former_identifier_tesim":["31935"],"thumbnail_path_ss":"/downloads/bg257k19n?file=thumbnail","suppressed_bsi":false,"actionable_workflow_roles_ssim":["admin_set/default-default-managing","admin_set/default-default-approving","admin_set/default-default-depositing"],"workflow_state_name_ssim":["deposited"],"member_ids_ssim":["sf268880p","bc386p01z","th83m297q","tx31qn22q","x920g1681","k930c1777","3b591d27m","sj139555k","jh343w990","7d278x384","70795c00b","5h73q0883","dj52w8305","8336h5695","1n79h7833","bg257k19n","5x21tk28q","ns064954x","70795b99s","qr46r463c","9k41zj269","2801pk983","ns064953n","cc08hk299","5t34sp40r","6969z4701","7w62fd17t","tb09j9681","pz50h096j","5999n689w","qj72pb85n","2v23vz129","r207tt00z","rj4308523","dj52w831f","h415pf40p","f4752m33r","6q182q180","kw52jc82p","fn1072837","n870zv52p","gm80hz91c","n009w569b","bz60d0947","wd376096v","c247dw93b","7w62fd183","k643b510t","tq57nv562","n009w5703","2r36v199w","0k225f61x","1j92gb83k","zs25xd16g","zc77st86x","gt54kr37b","9880vv67j","st74cv365","ns0649556","jd473153h","d791sm30c","7p88cm269","0p096b77b","9019s628j","m039k888w","z029p850q","xp68km21f","6108vf770","k643b5113","nz806349h","xw42nc38w","ww72bg13c","z603r215m"],"file_set_ids_ssim":["sf268880p","bc386p01z","th83m297q","tx31qn22q","x920g1681","k930c1777","3b591d27m","sj139555k","jh343w990","7d278x384","70795c00b","5h73q0883","dj52w8305","8336h5695","1n79h7833","bg257k19n","5x21tk28q","ns064954x","70795b99s","qr46r463c","9k41zj269","2801pk983","ns064953n","cc08hk299","5t34sp40r","6969z4701","7w62fd17t","tb09j9681","pz50h096j","5999n689w","qj72pb85n","2v23vz129","r207tt00z","rj4308523","dj52w831f","h415pf40p","f4752m33r","6q182q180","kw52jc82p","fn1072837","n870zv52p","gm80hz91c","n009w569b","bz60d0947","wd376096v","c247dw93b","7w62fd183","k643b510t","tq57nv562","n009w5703","2r36v199w","0k225f61x","1j92gb83k","zs25xd16g","zc77st86x","gt54kr37b","9880vv67j","st74cv365","ns0649556","jd473153h","d791sm30c","7p88cm269","0p096b77b","9019s628j","m039k888w","z029p850q","xp68km21f","6108vf770","k643b5113","nz806349h","xw42nc38w","ww72bg13c","z603r215m"],"visibility_ssi":"open","admin_set_tesim":["Default Admin Set"],"human_readable_type_tesim":["Published Work"],"read_access_group_ssim":["public"],"edit_access_group_ssim":["admin"],"edit_access_person_ssim":["batchuser@example.com"],"nesting_collection__pathnames_ssim":["000031935"],"nesting_collection__deepest_nested_depth_isi":1,"_version_":1717498745306742784,"timestamp":"2021-11-26T13:47:21.859Z","score":1.0},{"system_create_dtsi":"2021-11-04T22:52:53Z","system_modified_dtsi":"2021-11-20T22:32:43Z","has_model_ssim":["PublishedWork"],"id":"000024899","accessControl_ssim":["991a2906-72bb-49f6-b440-da468d01ee3c"],"hasRelatedMediaFragment_ssim":["wh246w780"],"hasRelatedImage_ssim":["wh246w780"],"depositor_ssim":["batchuser@example.com"],"depositor_tesim":["batchuser@example.com"],"title_tesim":["Health, wealth and medicines for all? : regulating the pharmaceutical industry for community benefit"],"date_uploaded_dtsi":"2021-11-04T22:52:53Z","date_modified_dtsi":"2021-11-11T06:30:09Z","isPartOf_ssim":["admin_set/default"],"biblionumber_tesim":["24899"],"abstract_tesim":["Close regulation of the pharmaceutical industry has been seen as essential for the protection of the public for most of the last century. Yet the interest of government and the public in the low-cost provision of medicines can often conflict with the existence of a strong, profitable and innovative pharmaceutical industry. This book explores the tensions between seemingly divergent goals, putting the role of pharmaceutical sector regulation into national and wider contexts. It gives an overview of the evolution of the UK pharmaceutical market and its control; describes the Pharmaceutical Price Regulation Scheme and other supply-and-demand-side interventions; and offers a number of suggestions for the future of medicines regulation and research."],"date_published_tesim":["2000"],"date_published_ssi":"2000","isbn_tesim":["1857174313"],"pagination_tesim":["63"],"place_of_publication_tesim":["London"],"rights_statement_tesim":["http://rightsstatements.org/vocab/InC/1.0/"],"license_tesim":["http://creativecommons.org/licenses/by-nc-nd/4.0/"],"creator_tesim":["Taylor, David","King's Fund","Tucker, Andrew"],"date_tesim":["2000"],"date_ssi":"2000","publisher_tesim":["King's Fund"],"resource_type_tesim":["Monograph"],"subject_tesim":["Regulations","Pharmaceutical industry","Prescribing","Prices"],"note_tesim":["Pagination: 63p."],"former_identifier_tesim":["24899"],"thumbnail_path_ss":"/downloads/wh246w780?file=thumbnail","suppressed_bsi":false,"actionable_workflow_roles_ssim":["admin_set/default-default-managing","admin_set/default-default-approving","admin_set/default-default-depositing"],"workflow_state_name_ssim":["deposited"],"member_ids_ssim":["p8418r90w","z890rx854","zs25xc98r","2f75rc67t","hq37vr780","9p290d734","qv33s124x","wh246w780","t148fm54p","jw827g287","bv73c416t","0p096b50x","dr26z180x","r781wk77t","1r66j496d","k930c154x","44558h54d","q524js477","q524js46z","9880vv43z","b5644w041","5q47rs22k","37720h26t","k0698c18j","np193d49t","9z9033590","ww72bf87z","n009w5461","1r66j4954","5712mb074","fj236545k","t435gh670","ww72bf887","f7623h11z","4f16c642m","vq27zs109","8p58ph391","pr76f685j","mc87pt69h","q811kp067","tx31qn03h","vd66w3741","6395wb423","tb09j953d","ks65hg52q","5425kd96k","r207ts738","np193d48j","m900nz476","4j03d311v","0z7091347","wm117s345","zs25xc991","0k225f42q","pv63g382z","pr76f6848","08612s18v","pz50h077b","1v53k166x","sj139537n","vm40xw00j","td96k607h","pk02cf22r","g732dd74w","gx41mn440","2v23vx921","k0698c19t","rb68xg43h","jh343w73v","05741v99m","0g354j91d","qb98mk21t","dz010t26k","5h73q067b","tq57nv32g","fj236546v","3197xq444"],"file_set_ids_ssim":["p8418r90w","z890rx854","zs25xc98r","2f75rc67t","hq37vr780","9p290d734","qv33s124x","wh246w780","t148fm54p","jw827g287","bv73c416t","0p096b50x","dr26z180x","r781wk77t","1r66j496d","k930c154x","44558h54d","q524js477","q524js46z","9880vv43z","b5644w041","5q47rs22k","37720h26t","k0698c18j","np193d49t","9z9033590","ww72bf87z","n009w5461","1r66j4954","5712mb074","fj236545k","t435gh670","ww72bf887","f7623h11z","4f16c642m","vq27zs109","8p58ph391","pr76f685j","mc87pt69h","q811kp067","tx31qn03h","vd66w3741","6395wb423","tb09j953d","ks65hg52q","5425kd96k","r207ts738","np193d48j","m900nz476","4j03d311v","0z7091347","wm117s345","zs25xc991","0k225f42q","pv63g382z","pr76f6848","08612s18v","pz50h077b","1v53k166x","sj139537n","vm40xw00j","td96k607h","pk02cf22r","g732dd74w","gx41mn440","2v23vx921","k0698c19t","rb68xg43h","jh343w73v","05741v99m","0g354j91d","qb98mk21t","dz010t26k","5h73q067b","tq57nv32g","fj236546v","3197xq444"],"visibility_ssi":"open","admin_set_tesim":["Default Admin Set"],"human_readable_type_tesim":["Published Work"],"read_access_group_ssim":["public"],"edit_access_group_ssim":["admin"],"edit_access_person_ssim":["batchuser@example.com"],"nesting_collection__pathnames_ssim":["000024899"],"nesting_collection__deepest_nested_depth_isi":1,"_version_":1717493004848070656,"timestamp":"2021-11-26T12:16:07.331Z","score":1.0},{"system_create_dtsi":"2021-10-27T20:59:51Z","system_modified_dtsi":"2021-10-28T13:40:34Z","has_model_ssim":["PublishedWork"],"id":"000034569","accessControl_ssim":["65eb36a3-7b3f-4bd2-a19f-f0c033cc3869"],"hasRelatedMediaFragment_ssim":["kh04dp681"],"hasRelatedImage_ssim":["kh04dp681"],"depositor_ssim":["batchuser@example.com"],"depositor_tesim":["batchuser@example.com"],"title_tesim":["Getting the right medicines? :  putting public interests at the heart of health-related research : summary."],"date_uploaded_dtsi":"2021-10-27T20:59:51Z","date_modified_dtsi":"2021-10-28T13:29:44Z","isPartOf_ssim":["admin_set/default"],"biblionumber_tesim":["34569"],"abstract_tesim":["Since its beginnings, the NHS has had a close relationship with the pharmaceutical industry. While not an official public-private partnership (PPP) there has been, in effect, an implicit PPP for pharmaceutical research and provision. This partnership has been an undoubted economic success. However, the interests of users of the health care system do not always coincide with what will be most profitable for the pharmaceutical industry. This publication argues that, because it is focussed on new medicinal drugs, the implicit PPP for pharmaceuticals neglects other research areas that may be beneficial for promoting people's health. It also omits key user groups and is therefore in danger of failing to meet the health needs of the very people it is supposed to be benefiting. It highlights where changes can be made to ensure there are sufficient incentives for research to tackle neglected areas that could be of value for improving health. It points the way forward towards a more transparent process with an emphasis on user involvement, and sets out the agenda on which future arrangements between the industry and the government should be negotiated.  This publication is the summary of the full research paper published separately. [Cover information abbreviated]"],"date_published_tesim":["2003"],"date_published_ssi":"2003","official_url_tesim":["http://www.kingsfund.org.uk/sites/files/kf/field/field_publication_file/getting-right-medicines-putting-public-interests-heart-health-related-research-tony-harrison-kings-fund-1-december-2003.pdf"],"pagination_tesim":["6p."],"place_of_publication_tesim":["London"],"creator_tesim":["Harrison, Anthony","The King's Fund"],"date_tesim":["2003"],"date_ssi":"2003","publisher_tesim":["King's Fund"],"subject_tesim":["Research","Pharmaceutical industry","General public","Health needs","NHS","Drugs"],"thumbnail_path_ss":"/downloads/kh04dp681?file=thumbnail","suppressed_bsi":false,"actionable_workflow_roles_ssim":["admin_set/default-default-managing","admin_set/default-default-approving","admin_set/default-default-depositing"],"workflow_state_name_ssim":["deposited"],"member_ids_ssim":["kh04dp681"],"file_set_ids_ssim":["kh04dp681"],"visibility_ssi":"open","admin_set_tesim":["Default Admin Set"],"human_readable_type_tesim":["Published Work"],"read_access_group_ssim":["public"],"edit_access_group_ssim":["admin"],"edit_access_person_ssim":["batchuser@example.com"],"nesting_collection__pathnames_ssim":["000034569"],"nesting_collection__deepest_nested_depth_isi":1,"_version_":1714878295538925568,"timestamp":"2021-10-28T15:36:26.218Z","score":1.0}],"facets":[{"name":"creator_sim","items":[{"value":"Harrison, Anthony","hits":2,"label":"Harrison, Anthony"},{"value":"The King's Fund","hits":2,"label":"The King's Fund"},{"value":"King's Fund","hits":1,"label":"King's Fund"},{"value":"Taylor, David","hits":1,"label":"Taylor, David"},{"value":"Tucker, Andrew","hits":1,"label":"Tucker, Andrew"}],"label":"Author"},{"name":"subject_sim","items":[{"value":"Pharmaceutical industry","hits":3,"label":"Pharmaceutical industry"},{"value":"Drugs","hits":2,"label":"Drugs"},{"value":"General public","hits":2,"label":"General public"},{"value":"Health needs","hits":2,"label":"Health needs"},{"value":"Research","hits":2,"label":"Research"},{"value":"NHS","hits":1,"label":"NHS"}],"label":"Subject"},{"name":"resource_type_sim","items":[{"value":"Monograph","hits":2,"label":"Monograph"}],"label":"Resource type"},{"name":"date_range_sim","items":[{"value":"2003","hits":2,"label":"2003"},{"value":"2000","hits":1,"label":"2000"}],"label":"Date Range"},{"name":"file_format_sim","items":[],"label":"File format"},{"name":"member_of_collections_ssim","items":[],"label":"Collection"},{"name":"generic_type_sim","items":[{"value":"Work","hits":3,"label":"Work"}],"label":"Generic Type Sim"}],"pages":{"current_page":1,"next_page":null,"prev_page":null,"total_pages":1,"limit_value":10,"offset_value":0,"total_count":3,"first_page?":true,"last_page?":true}}}